Stay up to date every week with the european biotechnology newsletter.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Comments

This field is for validation purposes and should be left unchanged.

BIOCOM CARD
Newsletter
Advertising
Job Market
Shop

Latest news
Background
Opinion
The Mag
- Issues
- Special
- Subscribe
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

Tag Archive for: Tumour Models London Summit

Nothing Found

Sorry, no posts matched your criteria

LATEST NEWS

Mallia Therapeutics

Mallia selects Northway to produce alopecia therapy

Bild von frimufilms auf Freepik

Aplagon secures €7m for APAC development

Bendo/European Commission

EC launches EU Biotech and Biomanufacturing Hub

MAGAZINE

1 / 4

Since the first antibody drug was approved back in 1986, monoclonal antibodies have emerged as the dominant class in the global US$417bn market for biologics. At the end of 2023, sales stood at more … mehr ➔

2 / 4

The first half of 2024 is history, and experts are divided on whether the financing nadir has been reached or even passed. There are very different figures for different types of treatments under … mehr ➔

3 / 4

The Three R (Replacement, Reduction and Refinement) principles developed over 60 years ago provide a framework for more humane lab animal testing and, more importantly, less of it. A range of in-vitro … mehr ➔

4 / 4

Radiopharmaceuticals have turned into a hot commodity when it comes to M&A financing and deals. Targeted therapies that employ high-energy attachments linked to antibodies, small molecules or … mehr ➔

❮❯